Medizin
Refine
Year of publication
- 2009 (269) (remove)
Document Type
- Doctoral Thesis (143)
- Article (95)
- Part of Periodical (15)
- Conference Proceeding (11)
- Book (2)
- Review (2)
- Working Paper (1)
Has Fulltext
- yes (269)
Is part of the Bibliography
- no (269)
Keywords
- Bronchialasthma (2)
- Brustkrebs (2)
- HIV (2)
- Lungenfunktion (2)
- Sepsis (2)
- ADAM10 (1)
- Adipositas Chirurgie (1)
- Adoptivkind (1)
- Allergie (1)
- Allgemeinmedizin (1)
- Alzheimer's disease (1)
- Aminosäuremetabolismus (1)
- Aminosäuren (1)
- Antigen CD62 (1)
- Arbeit (1)
- Arbeitsmedizin (1)
- Asthma (1)
- Asthmadiagnostik (1)
- Atemtest (1)
- Autistic disorder (1)
- Baby-Bodyplethysmographie (1)
- Bacterial intestinal overgrowth (1)
- Basel Consensus Statement (1)
- Basler Consensus Statement (1)
- Behandlungssystematik (1)
- Behandlungsumfang (1)
- Berufskrankheit (1)
- Biglycan (1)
- Bodyplethysmographie (1)
- Bologna process (1)
- Bologna-Prozess (1)
- Brain tumor (1)
- Breath testing (1)
- Bronchial challenge (1)
- Bronchiale Hyperreagibilität (1)
- Bundesärztekammer / Ausschuss Arbeitsmedizin (1)
- CD62 (1)
- CPET (1)
- CXCL16 (1)
- Children (1)
- Chronische Krankheit (1)
- Comorbidities (1)
- Complex Systems (1)
- Copy number variation (1)
- Cox-2-Inhibitoren (1)
- Cox-Regression (1)
- Cyclooxygenase (1)
- Cystic fibrosis (1)
- Decorin (1)
- Depression (1)
- Deutsche Gesellschaft für Arbeitsmedizin (1)
- Deutschland (1)
- Diagnostics (1)
- Diagnostik (1)
- Didaktik (1)
- Dipeptide (1)
- Doppler-Sonographie (1)
- Down's syndrome (1)
- EFP1 (1)
- ER stress (1)
- Endotoxikose (1)
- Endotoxin (1)
- Erwachsener (1)
- Explorative Data Analysis (1)
- Explorative Datenanalyse (1)
- Fibrosis (1)
- Freiburg im Breisgau <2009> (1)
- Frühgeborenes (1)
- Gender (1)
- Geschlecht (1)
- Gesundheit (1)
- Glucose (1)
- Glukose (1)
- Gonarthrose (1)
- HBV (1)
- HCV (1)
- HIV-Infektion (1)
- Heben (1)
- Heme-Oxygenase 1 (1)
- Hepatitis (1)
- Herzinfarkt (1)
- Hypertension (1)
- Hypertonie (1)
- Häm-Oxygenase 1 (1)
- Immunchemie (1)
- Immunität <Medizin> (1)
- Immunologie (1)
- Immunsuppression (1)
- Immunsystem (1)
- Infektiologie (1)
- Infektion (1)
- Inflammation (1)
- Innate immunity (1)
- Intestinale bakterielle Fehlbesiedelung (1)
- Kaplan-Meier-Schätzung (1)
- Kardiomyopathie (1)
- Kardiovaskuläre Krankheit (1)
- Kindheit (1)
- Kleinkind (1)
- Kniegelenkarthrose (1)
- Kombinationstherapie (1)
- Kombinationstherapien (1)
- Komorbiditäten (1)
- Kongress (1)
- Krankenhausfinanzierung (1)
- L1 cell-adhesion molecule (L1-CAM) (1)
- Laparscopic Bariatric Surgery (1)
- Leber (1)
- Leukozyt (1)
- Linkage (1)
- Longitudinal Study (1)
- Longitudinalstudie (1)
- Low birth weight infant (1)
- Lumican (1)
- Lymphozyt (1)
- Medizinische Ausbildung (1)
- Metastase (1)
- Methacholinprovokation (1)
- Methionine (1)
- Microglia (1)
- Mitochondria (1)
- Modell-Curriculum (1)
- Molecular imaging (1)
- Monitoring (1)
- Mukoviszidose (1)
- Multivariate Analyse (1)
- Mutation (1)
- Myokardinfarkt (1)
- Nephrogenese (1)
- Neugeborenes (1)
- Nierentransplantation (1)
- Obstruktive Bronchitis (1)
- Oxidative stress (1)
- PAC-1 (1)
- PC20 (1)
- PD20 (1)
- PDI (1)
- PET (1)
- PINK1 (1)
- Par-4 (1)
- Parkin (1)
- Parkinson’s disease (1)
- Persönlichkeitsfaktor (1)
- Plättchenaktivierung (1)
- Primary care (1)
- Prädiktor (1)
- Präkonditionierung (1)
- Prüfung (1)
- Psychometrie (1)
- Reform (1)
- Renin-Angiotensin-Aldosteron-System (1)
- Resistenz (1)
- Sexualität (1)
- Spiroergometrie (1)
- Stammzelle (1)
- Stammzelltherapie (1)
- Suicidality (1)
- Suizidalität (1)
- Therapy (1)
- Thrombozytenaggregation (1)
- Thrombozytenaktivierung (1)
- Tragen (1)
- Ultraschallkontrastmittel (1)
- Univariate Analyse (1)
- Unspezifische Provokation (1)
- Wheezy infants (1)
- Whole genome association (1)
- Wissenschaftsgeschichte (1)
- Xylose (1)
- Zahnmedizin (1)
- Zahnärztliche Behandlung (1)
- a disintegrin and metalloprotease 10 (ADAM10) (1)
- acute myocardial infarction (1)
- aggression (1)
- aging (1)
- airway obstruction (1)
- amino acids (1)
- analgesics (1)
- apoptosis (1)
- asthma (1)
- augmentation materials (1)
- baby-bodyplethysmography (1)
- back pain (1)
- behavioral performance (1)
- biocompatibility (1)
- brain imaging (1)
- branched-chain amino acids (BCAA) (1)
- breast cancer cells (1)
- bronchial hyperresponsiveness (1)
- cardiovascular event (1)
- cerebral autoregulation (1)
- cerebrale Autoregulation (1)
- childhood (1)
- coauthor ship (1)
- cognition (1)
- combination therapies (1)
- communication/social competencies (1)
- computational neuroscience (1)
- conduct disorder (1)
- cortex (1)
- cox-2-inhibitors (1)
- cyclooxygenases (1)
- dementia (1)
- diabetic nephropathy (1)
- didactic (1)
- dipeptide (1)
- doppler-sonography (1)
- endocarditis (1)
- endotheliale Progenitorzellen (1)
- endotoxin (1)
- exercise (1)
- extracellular matrix (1)
- fMRI (1)
- facial prosthesis (1)
- gamma (1)
- h-index (1)
- heavy (1)
- impact factor (1)
- implanto-prosthetic therapy (1)
- intervertebral disc (1)
- intravital microscopy (1)
- ischämische (1)
- knee (1)
- kommunikative/soziale Kompetenzen (1)
- lifting (1)
- liver (1)
- local field potential (1)
- low birth weight infant (1)
- medizinische Ausbildung (1)
- metastatic breast cancer (1)
- methacholine (1)
- microcirculation (1)
- mino acid metabolism (first pass) (1)
- model curriculum (1)
- monitoring (1)
- multivariate analysis (1)
- myocarditis (1)
- neonatal septic shock (1)
- nephrogenesis (1)
- neuropathic pain (1)
- newborn infant (1)
- nonlinear dynamics (1)
- nuclear translocation (1)
- obstruktive Bronchitiden (1)
- occupation (1)
- oscillations (1)
- osteoarthritis (1)
- overall survival (1)
- pericarditis (1)
- platelet activation (1)
- podocytes (1)
- polymorphism (1)
- pre-conditioning (1)
- predictor (1)
- prefrontal cortex (1)
- premature infant (1)
- presenilin (PS)/gamma-secretase activity (1)
- primary tubular cells (1)
- protein C (1)
- psychiatry (1)
- quantum biology (1)
- renin-angiotensin-aldosterone-system (1)
- routine care (1)
- scientometrics (1)
- self-citation (1)
- sepsis (1)
- stem cell therapy (1)
- stimulus coding (1)
- survival analysis (1)
- synchrony (1)
- systemical treatment (1)
- testing (1)
- thioredoxin (1)
- transcranial (1)
- transcraniell (1)
- treatment scale (1)
- triple-negativen Mammakarzinomzellen (1)
- ultrasound contrast agent (1)
- undergraduate medical education (1)
- univariate analysis (1)
- verzweigtkettige Aminosäuren (1)
- violence (1)
- visual short-term memory (1)
- Überleben (1)
- Überlebenszeitanalyse (1)
Institute
Background Public health systems are confronted with constantly rising costs. Furthermore, diagnostic as well as treatment services become more and more specialized. These are the reasons for an interdisciplinary project on the one hand aiming at simplification of planning and scheduling patient appointments, on the other hand at fulfilling all requirements of efficiency and treatment quality. Methods As to understanding procedure and problem solving activities, the responsible project group strictly proceeded with four methodical steps: actual state analysis, analysis of causes, correcting measures, and examination of effectiveness. Various methods of quality management, as for instance opinion polls, data collections, and several procedures of problem identification as well as of solution proposals were applied. All activities were realized according to the requirements of the clinic's ISO 9001:2000 certified quality management system. The development of this project is described step by step from planning phase to inauguration into the daily routine of the clinic and subsequent control of effectiveness. Results Five significant problem fields could be identified. After an analysis of causes the major remedial measures were: installation of a patient telephone hotline, standardization of appointment arrangements for all patients, modification of the appointments book considering the reason for coming in planning defined working periods for certain symptoms and treatments, improvement of telephonic counselling, and transition to flexible time planning by daily updates of the appointments book. After implementation of these changes into the clinic's routine success could be demonstrated by significantly reduced waiting times and resulting increased patient satisfaction. Conclusion Systematic scrutiny of the existing organizational structures of the outpatients' department of our clinic by means of actual state analysis and analysis of causes revealed the necessity of improvement. According to rules of quality management correcting measures and subsequent examination of effectiveness were performed. These changes resulted in higher satisfaction of patients, referring colleagues and clinic staff the like. Additionally the clinic is able to cope with an increasing demand for appointments in outpatients' departments, and the clinic's human resources are employed more effectively.
Background Ongoing changes in cancer care cause an increase in the complexity of cases which is characterized by modern treatment techniques and a higher demand for patient information about the underlying disease and therapeutic options. At the same time, the restructuring of health services and reduced funding have led to the downsizing of hospital care services. These trends strongly influence the workplace environment and are a potential source of stress and burnout among professionals working in radiotherapy. Methods and patients A postal survey was sent to members of the workgroup "Quality of Life" which is part of DEGRO (German Society for Radiooncology). Thus far, 11 departments have answered the survey. 406 (76.1%) out of 534 cancer care workers (23% physicians, 35% radiographers, 31% nurses, 11% physicists) from 8 university hospitals and 3 general hospitals completed the FBAS form (Stress Questionnaire of Physicians and Nurses; 42 items, 7 scales), and a self-designed questionnaire regarding work situation and one question on global job satisfaction. Furthermore, the participants could make voluntary suggestions about how to improve their situation. Results Nurses and physicians showed the highest level of job stress (total score 2.2 and 2.1). The greatest source of job stress (physicians, nurses and radiographers) stemmed from structural conditions (e.g. underpayment, ringing of the telephone) a "stress by compassion" (e.g. "long suffering of patients", "patients will be kept alive using all available resources against the conviction of staff"). In multivariate analyses professional group (p < 0.001), working night shifts (p = 0.001), age group (p = 0.012) and free time compensation (p = 0.024) gained significance for total FBAS score. Global job satisfaction was 4.1 on a 9-point scale (from 1 – very satisfied to 9 – not satisfied). Comparing the total stress scores of the hospitals and job groups we found significant differences in nurses (p = 0.005) and physicists (p = 0.042) and a borderline significance in physicians (p = 0.052). In multivariate analyses "professional group" (p = 0.006) and "vocational experience" (p = 0.036) were associated with job satisfaction (cancer care workers with < 2 years of vocational experience having a higher global job satisfaction). The total FBAS score correlated with job satisfaction (Spearman-Rho = 0.40; p < 0.001). Conclusion Current workplace environments have a negative impact on stress levels and the satisfaction of radiotherapy staff. Identification and removal of the above-mentioned critical points requires various changes which should lead to the reduction of stress.
Mitochondria are essential for respiration and oxidative phosphorylation. Mitochondrial dysfunction due to aging processes is involved in pathologies and pathogenesis of a series of cardiovascular disorders. New results accumulate showing that the enzyme telomerase with its catalytic subunit telomerase reverse transcriptase (TERT) has a beneficial effect on heart functions. The benefit of short-term running of mice for heart function is dependent on TERT expression. TERT can translocate into the mitochondria and mitochondrial TERT (mtTERT) is protective against stress induced stimuli and binds to mitochondrial DNA (mtDNA). Because mtDNA is highly susceptible to damage produced by reactive oxygen species (ROS) which are generated in close proximity to the respiratory chain, the aim of this study was to determine the functions of mtTERT in vivo and in vitro. Therefore, mitochondria from hearts of adult, 2nd generation TERT-deficient mice (TERT -/-) and wt littermates were isolated and state 3 respiration was measured. Strikingly mitochondria from TERT -/- revealed a significantly lower state 3 respiration (TERTwt: 987 +/- 72 pmol/s*mg vs. TERT-/-: 774 +/- 38 pmol/s*mg, p < 0.05, n = 5). These results demonstrated that TERT -/- mice have a so far undiscovered heart phenotype. In contrast mitochondria isolated from liver tissues did not show any differences. To get further insights in the molecular mechanisms, we reduced endogenous TERT levels by shRNA and measured mitochondrial reactive oxygen species (mtROS). mtROS were increased after ablation of TERT (scrambled: 4.98 +/- 1.1% gated vs. shTERT: 2.03 +/- 0.7% gated, p < 0.05, n = 4). We next determined mtDNA deletions, which are caused by mtROS. Semiquantitative realtime PCR of mtDNA deletions revealed that mtTERT protects mtDNA from oxidative damage. To analyze whether mitochondrial integrity is required to protect from apoptosis, vectors with mitochondrially targeted TERT (mitoTERT) and wildtype TERT (wtTERT) were transfected and apoptosis was measured. mitoTERT showed the most prominent protective effect on H2O2 induced apoptosis. In conclusion, mtTERT has a protective role in mitochondria by importantly contributing to mtDNA integrity and thereby enhancing respiration capacity of the heart.
Introduction: Lymphocyte infiltration (LI) is often seen in breast cancer but its importance remains controversial. A positive correlation of human epidermal growth factor receptor 2 (HER2) amplification and LI has been described, which was associated with a more favorable outcome. However, specific lymphocytes might also promote tumor progression by shifting the cytokine milieu in the tumor.
Methods: Affymetrix HG-U133A microarray data of 1,781 primary breast cancer samples from 12 datasets were included. The correlation of immune system-related metagenes with different immune cells, clinical parameters, and survival was analyzed.
Results: A large cluster of nearly 600 genes with functions in immune cells was consistently obtained in all datasets. Seven robust metagenes from this cluster can act as surrogate markers for the amount of different immune cell types in the breast cancer sample. An IgG metagene as a marker for B cells had no significant prognostic value. In contrast, a strong positive prognostic value for the T-cell surrogate marker (lymphocyte-specific kinase (LCK) metagene) was observed among all estrogen receptor (ER)-negative tumors and those ER-positive tumors with a HER2 overexpression. Moreover ER-negative tumors with high expression of both IgG and LCK metagenes seem to respond better to neoadjuvant chemotherapy.
Conclusions: Precise definitions of the specific subtypes of immune cells in the tumor can be accomplished from microarray data. These surrogate markers define subgroups of tumors with different prognosis. Importantly, all known prognostic gene signatures uniformly assign poor prognosis to all ER-negative tumors. In contrast, the LCK metagene actually separates the ER-negative group into better or worse prognosis.
Background Imatinib mesylate, a selective inhibitor of Abl tyrosine kinase, is efficacious in treating chronic myeloid leukaemia (CML) and Ph+ acute lymphoblastic leukaemia (ALL). However, most advanced-phase CML and Ph+ ALL patients relapse on Imatinib therapy. Several mechanisms of refractoriness have been reported, including the activation of the Src-family kinases (SFK). Here, we investigated the biological effect of the new specific dual Src/Abl kinase inhibitor AZD0530 on Ph+ leukaemic cells. Methods Cell lines used included BV173 (CML in myeloid blast crisis), SEM t(4;11), Ba/F3 (IL-3 dependent murine pro B), p185Bcr-Abl infected Ba/F3 cells, p185Bcr-Abl mutant infected Ba/F3 cells, SupB15 (Ph+ ALL) and Imatinib resistant SupB15 (RTSupB15) (Ph+ ALL) cells. Cells were exposed to AZD0530 and Imatinib. Cell proliferation, apoptosis, survival and signalling pathways were assessed by dye exclusion, flow cytometry and Western blotting respectively. Results AZD0530 specifically inhibited the growth of, and induced apoptosis in CML and Ph+ ALL cells in a dose dependent manner, but showed only marginal effects on Ph- ALL cells. Resistance to Imatinib due to the mutation Y253F in p185Bcr-Abl was overcome by AZD0530. Combination of AZD0530 and Imatinib showed an additive inhibitory effect on the proliferation of CML BV173 cells but not on Ph+ ALL SupB15 cells. An ongoing transphosphorylation was demonstrated between SFKs and Bcr-Abl. AZD0530 significantly down-regulated the activation of survival signalling pathways in Ph+ cells, resistant or sensitive to Imatinib, with the exception of the RTSupB15. Conclusion Our results indicate that AZD0530 targets both Src and Bcr-Abl kinase activity and reduces the leukaemic maintenance by Bcr-Abl.
Background The effect of additional treatment strategies with antineoplastic agents on intraperitoneal tumor stimulating interleukin levels are unclear. Taurolidine and Povidone-iodine have been mainly used for abdominal lavage in Germany and Europe. Methods In the settings of a multicentre (three University Hospitals) prospective randomized controlled trial 120 patients were randomly allocated to receive either 0.5% taurolidine/2,500 IU heparin (TRD) or 0.25% povidone-iodine (control) intraperitoneally for resectable colorectal, gastric or pancreatic cancers. Due to the fact that IL-1beta (produced by macrophages) is preoperatively indifferent in various gastrointestinal cancer types our major outcome criterion was the perioperative (overall) level of IL-1beta in peritoneal fluid. Results Cytokine values were significantly lower after TRD lavage for IL-1beta, IL-6, and IL-10. Perioperative complications did not differ. The median follow-up was 50.0 months. The overall mortality rate (28 vs. 25, p = 0.36), the cancer-related death rate (17 vs. 19, p = .2), the local recurrence rate (7 vs. 12, p = .16), the distant metastasis rate (13 vs. 18, p = 0.2) as well as the time to relapse were not statistically significant different. Conclusion Reduced cytokine levels might explain a short term antitumorigenic intraperitoneal effect of TRD. But, this study analyzed different types of cancer. Therefore, we set up a multicentre randomized trial in patients undergoing curative colorectal cancer resection. Trial registration : ISRCTN66478538
Background The differential diagnosis between follicular thyroid adenoma and minimal invasive follicular thyroid carcinoma is often difficult for several reasons. One major aspect is the lack of typical cytological criteria in well differentiated specimens. New marker molecules, shown by poly- or monoclonal antibodies proved helpful. Methods We performed global gene expression analysis of 12 follicular thyroid tumours (4 follicular adenomas, 4 minimal invasive follicular carcinomas and 4 widely invasive follicular carcinomas), followed by immunohistochemical staining of 149 cases. The specificity of the antibody was validated by western blot analysis Results In gene expression analysis QPRT was detected as differently expressed between follicular thyroid adenoma and follicular thyroid carcinoma. QPRT protein could be detected by immunohistochemistry in 65% of follicular thyroid carcinomas including minimal invasive variant and only 22% of follicular adenomas. Conclusion Consequently, QPRT is a potential new marker for the immunohistochemical screening of follicular thyroid nodules.
Die derzeitige Therapie der chronischen Hepatitis C ist komplex und mit zahlreichen Nebenwirkungen assoziiert. Um den Therapieerfolg frühzeitig vorhersagen zu können und die Behandlung individuell zu optimieren, greifen Forscher des Frankfurter Leberzentrums auf mathematische Modellierung zurück. ...
Die Koronare Herzkrankheit (KHK) und der Akute Myokardinfarkt (AMI) sind die beiden häufigsten Todesursachen in den westlichen Industrienationen. In der Folge einer chronischen oder akuten ischämischen Schädigung des Herzens kommt es unter anderem zum Umbau insbesondere des linken Ventrikels, dem so genannten „Cardiac Remodeling“, das in den meisten Fällen mitverantwortlich für die Entstehung einer Herzinsuffizienz ist. Diverse Studien haben in den vergangenen Jahren gezeigt, dass die kardiale Stamm- oder Progenitorzelltherapie ein viel versprechender Ansatz ist, die Regeneration eines ischämisch geschädigten Herzens zu unterstützen und das „Cardiac Remodeling“ zu begrenzen. In diesem Zusammenhang wurden sowohl verschiedene Arten von Stammzellen, als auch verschiedene Applikationstechniken eingesetzt. Auf welchen Wegen die eingesetzten Stamm- oder Progenitorzellen ihre Wirkung entfalten ist bislang nicht abschließend geklärt. Eine Grundvoraussetzung um zur Regeneration des Myokards beitragen zu können ist jedoch, dass die Zellen nach der intrakoronaren Applikation in das Gewebe transmigrieren und dort anwachsen. Um neue Erkenntnisse über die Mechanismen, die Abläufe und die prädiktiven Faktoren dieses als „Homing“ bezeichneten Vorgangs zu gewinnen, wurden zwischen 2005 und 2007 am Klinikum der Johann Wolfgang Goethe-Universität 20 Patienten mit 111Inmarkierten autologen ex-vivo-kultivierten endothelialen Progenitorzellen behandelt und in den folgenden drei Tagen mittels Ganzkörperszintigraphie und SPECT nachuntersucht. Dabei zeigte sich, dass die 111In-Aktivität im Herzen innerhalb der ersten 24 Stunden bei der Gruppe der Patienten mit Myokardinfarkt innerhalb der letzten 14 Tag signifikant höher (6,3 + 2,9%) war, als bei der Gruppe, deren Infarkt länger als 14 Tage aber kürzer als ein Jahr zurücklag (4,5 + 3,2%). Die geringste 111In-Aktivität (2,5 + 1,6%) zeigten Patienten mit länger als einem Jahr zurückliegender oder chronischer Ischämie (p = 0,042). In der Gruppe der akuten (< 14 Tage) und subakuten (14 Tage bis 1 Jahr) Ischämien zeigte sich ebenfalls, dass eine geringere Viabilität der betroffenen Areale im durchgeführten 18FDG-PET das Homing der Zellen ebenfalls günstig beeinflusst (p = 0,039), während die Viabilität in der Gruppe der chronischen Ischämien (> 1 Jahr) nicht signifikant mit der 111In-Aktivität korrelierte (p = 0,88). Des Weiteren zeigte sich, dass bei Patienten mit AMI innerhalb der letzten 12 Monate eine eingeschränkte koronare Flussreserve als Ausdruck einer gestörten Mikrozirkulation die Aufnahme 111In-markierter EPCs ebenfalls günstig beeinflusst (p = 0,048). Zusammenfassend erscheinen demnach das Alter des Infarktes, das Ausmaß der entstandenen Gewebsschädigung und der Umfang der verbliebenen mikrozirkulatorischen Funktion des Herzens die Faktoren zu sein, die das „Homing“ intrakoronar applizierter Progenitorzellen wesentlich beeinflussen. Dennoch konnte auch die vorliegende Studie keinen endgültigen Aufschluss darüber geben, auf welche Weise die applizierten Stammzellen ihre Wirkung am Herzen entfalten. Hier werden weiterhin die Vaskulogenese, die Differenzierung in funktionsfähige Kardiomyozyten ebenso wie parakrine Effekte, beispielsweise durch den SDF-1/CXCR4-Mechanismus, oder VEGF diskutiert. Letztlich bietet die vorliegende Studie jedoch eine Datenbasis für künftige Studien, die sich mit der Verbesserung, insbesondere der Technik der kardialen Progenitorzelltherapie, auseinandersetzen.